Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Investigating the Effect of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers of Mullerian Origin

NCT02728830 is registered in ClinicalTrials.gov with AA Secord as lead sponsor.

NCT NCT02728830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02728830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Investigating the Effect of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers of Mullerian Origin
Lead sponsor
AA Secord
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2016
Completion date
January 31, 2022
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial ovarian cancer, fallopian tube cancer, gynecologic neoplasms, peritoneal cancer, uterine endometrial cancer